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collections have been created for currently running in silico clinical 
trials (ROCOCO and THUNDER), as well as public collections with 
datasets used for QA and PET calibration, pre-clinical HX4 PET imaging 
of rats and transcriptome profiling of cancer cell lines. Data upload 
facilities have been prepared to support supplying remote centres 
with de-identification of the datasets in a trusted environment. 
Download functionality has successfully been tested using the CTMM-
TraIT (www.bmia.nl) and NCI NBIA (imaging.nci.nih.gov) instances. 
Full DICOM query and retrieve functionality is currently being added 
to the platform. 
Conclusions: With CancerData.org we have successfully set up an 
open source data sharing service for the oncology community. We 
extended the platform for non-DICOM (non-imaging) datasets and are 
in the process of extending collections as well as connectivity options. 
The radiotherapy community should consider compulsory storage of 
published datasets as 'open data' as it has been done for years for 
genomic data. We believe the privacy issues can be solved with the 
concept of 'anonymous de facto' data. 
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Purpose/Objective: Nowadays the use of Co-60 high dose rate (HDR) 
sources in brachytherapy is increasing quickly. The higher energy of 
Co-60 compared to Ir-192 increases direct radiation shielding for Co-
60. In the absence of procedures for evaluating the design of a 
brachytherapy vault including a maze from the point of view of 
radiation protection, the methodology employed by the physics 
community is very diverse: (i) considering only the direct component 
through the maze taking into account the distance from the source to 
the front wall plus the distance from it to the maze entrance or (ii) 
with different approaches based on the linac door calculations on 
NCRP-151 Structural Shielding Design for Megavoltage X-and Gamma-
Ray Radiotherapy Facilities. The purpose of this study is to evaluate 
the kerma at the maze entrance following a selected approach from 
NCRP-151. This is validated by using Monte Carlo (MC) techniques for 
two typical HDR Co-60 bunker designs. 
Materials and Methods: We have performed transmission calculations 
for primary and scattered radiation based on an adaptation of the 
NCRP-151. Specific Albedo and attenuation coefficients on ordinary 
concrete for Co-60 were taken into account. To verify the results of 
our approach, the MC GEANT4 code has been used to obtain kerma in 
the two bunkers. The source was placed at 1 m from the floor inside 
the bunker. The direct transmission, simple-scatter and double-
scatter components of the radiation emitted by the source have been 
obtained using our calculation method adapted from NCRP-151. We 
have considered the wall area that can be seen from the maze 
entrance for the calculation of the single-scatter component, the 
remaining wall area for the double-scatter component and direct 
calculation through the maze interior wall assuming perpendicular 
incidence of the radiation in the barrier for the primary component. In 
the MC calculations the radiation spectra has been obtained also in 
the door. 
Results: For the bunkers studied, kerma values at the entrance of the 
maze are or the order of 2×10-8cGy/(hU) (Figure 1). The results of MC 
and NCRP-151 differ less than 10%. For a Co-60 source, due to the 
higher photon energy, the double-scatter component is negligible.The 
direct transmission through the wall of the maze plays an important 
role for mazes less than 1 m wide and decrease for wider mazes. 
 
 Figure 1. Kerma obtained with MC in a bunker of this study. 
 
Conclusions: For the specific cases of this study, the proposed 
adaptation of the NCRP-151 formalism to estimate the absorbed dose 
at the maze entrance provides a result in reasonable agreement to 
that obtained by MC simulation. 
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Purpose/Objective: The work is focused on the assessment of 
secondary doses to healthy tissues that are delivered by the use of 
modern radiation therapy and diagnostics imaging modalities in the 
clinical environment. Ionising radiation is used increasingly for the 
treatment of cancer being the source of a considerable fraction of the 
artificial irradiation to the patient. Correlated with the advances in 
health care that have resulted in longer life expectancies, this has 
created the premises for an increase in the cancer incidence among 
the long-time survivors of radiotherapy. This is especially important 
for paediatric patients who, after a successful treatment, may live 
long and be more susceptible to secondary cancers. Also, diagnostics 
imaging modalities like CT and PET due to repeated imaging sessions 
are the source of significant radiation exposure associated with higher 
risk of occurrence of secondary cancers.  
Materials and Methods: In these studies the MC code SHIELD-HIT was 
used to calculate absorbed dose and energy spectra of primary and 
secondary particles generated during the ion beam transport through 
phantoms representing female, male and child patients. The doses 
due to photoneutron reactions were evaluated by measurements 
around photon therapy units at the hospitals in Sweden using 
activation foil method and a developed technique with a 235U fission 
chamber. Assessment of the secondary doses due to the imaging 
modalities is based on the literature studies. 
Results: Photonuclear production and secondary radiation doses 
around high energy medical electron accelerators of 16-50 MV located 
at the hospitals in Sweden have been evaluated. The level of 
secondary absorbed doses outside the treated volume due to the 
produced photoneutrons was in general less than 0.4 mGy per photon 
Gy delivered to the target volume. For light ion therapy, the 
secondary organ absorbed doses were calculated by Monte Carlo 
simulations with the SHIELD-HIT code coupled with the mathematical 
anthropomorphic phantoms ADAM-HIT, EVA-HIT and CHILD-HIT for 
irradiation with 1H, 4He, 7Li, 12C and 16O ion beams in the energy range 
100–400 MeV/u . The evaluated absorbed doses to the out-of-field 
organs were in the range 10-6 to 10-1 mGy per target Gy and with 
standard deviations 0.5–20 %. The secondary doses from light ion and 
X-rays therapy are compared with the doses from diagnostics imaging 
modalities like CT and PET.  
Conclusions: Evaluation of absorbed and equivalent doses to organs or 
tissues due to secondary radiation in photon, light ion therapy and 
diagnostics imaging modalities is an important step in the risk 
evaluation for induction of secondary cancers. The introduction of 
new treatment and diagnostic approaches could increase the risk 
levels, especially due to repeated imaging sessions.  
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Purpose/Objective: The purpose was to design and implement a 
comprehensive computerised calculation program to execute 
radiation-shielding evaluations for radiotherapy. The program 
addresses both individual and collective contributing factors that are 
intrinsic to shielding calculations e.g. building construction, treatment 
equipment and delivery techniques, workload and occupancy. It 
incorporates modern and emerging novel treatment delivery 
techniques and the resulting overall effects on radiation protection 
required. The secondary aim was to verify the shielding program by 
applying it to existing bunkers where measurements of photon and 
neutron doserate were made and to identify its advantages for 
modelling future radiotherapy bunkers. 
Materials and Methods: The calculation methods used to establish the 
photon and associated neutron dose rates employ the theoretical 
approach from the NCRP Report 151, and the IAEA Safety Report No. 
47, among others. The advantage of including new treatment 
techniques (extra-cranial stereotactic and ablative RT,VMAT, FFF, 
robotic radio-surgery) and newly available constructional materials 
improves the usefulness of the program for any radiotherapy centre. 
The program can evaluate existing bunkers for changes in workload, 
treatment technique or delivery. It contains all variables to enable 
modelling of a new build using concrete,high-density materials and 
layered materials. Calculations using actual workload compared to 
'worst -case' scenarios and the consequences on construction costs 
were evaluated. The contributions of photon, neutron scatter and 
neutron capture gamma rays were investigated with differing maze 
geometries. Special topics such as skyshine and ozone production 
were included too. The program includes all necessary TVLs and other 
intrinsic data, for modelling the spectrum of nominal photon energies 
clinically available, including flattened and flattening-filter-free (FFF) 
beam data. 
Results: The program’s logic and accuracy was successfully validated 
by comparison to literature and using measurements taken at two 
sites with different bunker designs. The program was used to 
calculate potential shielding changes to an existing bunker due to 
increasing the beam energy. The results showed adequate shielding 
except at the maze entrance. The impact of actual workloads versus 
theorised workload was also investigated. There was a 10-20% 
reduction in shielding when the workload theorised in 2003 was 
compared to actual 2012 workload for three bunkers, which could 
reduce the building costs by 10%. 
Conclusions: A comprehensive calculation program for bunker 
shielding was developed to include contemporary and emerging 
treatment methods. Its accuracy and functionality were proven in the 
case studies. It is more functional and manageable than previous 
programs used at the institution.  
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Purpose/Objective: To teach and train a large group of medical 
physicists, dosimetrists and radiation oncologists, working in different 
centres, in proton treatment planning. 
Materials and Methods: A common treatment planning system (TPS) 
for protons is since January 2012 installed and accessible for users in 
seven hospitals. We formed a school to provide the group with a 
common knowledgebase in proton treatment planning. The school 
started with a face-to-face meeting with lectures and workshops and 
continued with biweekly teleconferences. Prior to the teleconference 
the centres were expected to create treatment plans for selected 
patient cases in the common TPS. During the teleconferences, led by 
a chairman, the desktop of the common TPS was shared for everyone 
to view. The teleconferences consisted mainly of discussions about 
the suggested plans, patient fixation, VOI margins, dose distributions 
and plan robustness. We used a check-list to make sure we evaluated 
most relevant issues. After half a year, we changed focus and each 
centre in turn presented a case from their own database. A proton 
plan was created and compared with the actually given photon plan. 
Also here a checklist was used. To prepare for these sessions a number 
of scientific articles regarding related topics were distributed for 
discussions in the group. The TPS vendor also provided a proton 
planning course for this group. A second face-to-face meeting will 
deal with topics like creating common methods for different 
treatment sites, CT calibration, target delineation and study 
protocols. Yet another issue will be to plan future projects for the 
school, e.g. the possibility to invite external lecturers to the school. 
Results: The school has worked out well. All centres have participated 
actively both in planning and discussing, helping each other in gaining 
experience in a field where we are novices, and where the experience 
of this TPS varied within the group. It has been demanding to get the 
radiation oncologists involved. There may be several reasons for this; 
lack of staff, the school has not been properly entered into their work 
schedule or that they are merely used to evaluate plans, rather than 
to discuss the planning process itself, which has been an important 
part of the school. 
Conclusions: The concept is good for any topic were a common base 
line in knowledge is needed, but also as a mean to raise this level. It 
can be used for almost any topic, any number of participants and from 
any computer with a web camera to a conference room with a full 
scale teleconference system. Nevertheless the initial form may need 
revision over time to fit the purpose and the participants. A high 
standard of the teleconference systems is helpful when many people 
are participating. 
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Purpose/Objective: To investigate the association between various 
risk factors, including single nucleotide polymorphisms (SNPs) in 
candidate genes involved in radiation response, and late complications 
to radiotherapy in nasopharyngeal cancer patients. 
Materials and Methods: 155 patients were included in the study. 
Normal tissue fibrosis was scored using RTOG/EORTC grading system. 
11 candidate genes (ATM, XRCC1, XRCC3, XRCC4, XRCC5, PRKDC, 
LIG4, TP53, HDM2, CDKN1A, TGFB1) were selected for their presumed 
influence on radiosensitivity. 45 SNPs (12 primary and 33 neighboring) 
were genotyped by direct genomic DNA sequencing. 
Results: Patients with severe fibrosis (cases, G3-4, n = 48) were 
compared to controls (G0-2, n = 107). Univariate analysis showed 
significant association (P < 0.05) with radiation complications for 6 
SNPs (ATM G/A rs1801516, HDM2 promoter T/G rs2279744 and T/A 
rs1196333, XRCC1 G/A rs25487, XRCC5 T/C rs1051677 and TGFB1 C/T 
rs1800469). In addition, Kaplan-Meier analyses have also invoked 
significant association between genotypes and length of patients' 
follow up after radiotherapy. Multivariate logistic regression has 
further sustained these results suggesting predictive and prognostic 
roles of SNPs. 
Conclusions: Univariate and multivariate analysis suggest that 
radiation toxicity in radiotherapy patients are associated with certain 
SNPs, in genes involved in DNA repair pathways, including HDM2 gene 
promoter studied for the 1st time. In addition, radiosensitive patients 
harbored significantly higher number of risk alleles than controls (P < 
0.001). These results support the use of SNPs as genetic predictive 
markers for clinical radiosensitivity and the use of genotypes 
containing protective alleles as prognostic markers for patients' length 
of follow up after radiotherapy. Funded by KFSHRC grant 2000 031 and 
2040 025.  
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